117 related articles for article (PubMed ID: 37681557)
1. Diminazene aceturate-induced cytotoxicity is associated with the deregulation of cell cycle signaling and downregulation of oncogenes Furin, c-MYC, and FOXM1 in human cervical carcinoma Hela cells.
Gharbaran R; Sayibou Z; Atamturktur S; Ofosu-Mensah JJ; Soto J; Boodhan N; Kolya S; Onwumere O; Chang L; Somenarain L; Redenti S
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23527. PubMed ID: 37681557
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice.
Qiu Y; Shil PK; Zhu P; Yang H; Verma A; Lei B; Li Q
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3809-18. PubMed ID: 24854854
[TBL] [Abstract][Full Text] [Related]
3. Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology.
Qi Y; Zhang J; Cole-Jeffrey CT; Shenoy V; Espejo A; Hanna M; Song C; Pepine CJ; Katovich MJ; Raizada MK
Hypertension; 2013 Oct; 62(4):746-52. PubMed ID: 23959549
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-κB pathways in human retinal pigment epithelium.
Tao L; Qiu Y; Fu X; Lin R; Lei C; Wang J; Lei B
J Neuroinflammation; 2016 Feb; 13():35. PubMed ID: 26862037
[TBL] [Abstract][Full Text] [Related]
5. Topical administration of diminazene aceturate decreases inflammation in endotoxin-induced uveitis.
Zheng C; Lei C; Chen Z; Zheng S; Yang H; Qiu Y; Lei B
Mol Vis; 2015; 21():403-11. PubMed ID: 25883526
[TBL] [Abstract][Full Text] [Related]
6. The ACE 2 activator diminazene aceturate (DIZE) improves left ventricular diastolic dysfunction following myocardial infarction in rats.
Castardeli C; Sartório CL; Pimentel EB; Forechi L; Mill JG
Biomed Pharmacother; 2018 Nov; 107():212-218. PubMed ID: 30092400
[TBL] [Abstract][Full Text] [Related]
7. Short-term treatment with diminazene aceturate ameliorates the reduction in kidney ACE2 activity in rats with subtotal nephrectomy.
Velkoska E; Patel SK; Griggs K; Pickering RJ; Tikellis C; Burrell LM
PLoS One; 2015; 10(3):e0118758. PubMed ID: 25786223
[TBL] [Abstract][Full Text] [Related]
8. Diminazene aceturate improves autonomic modulation in pulmonary hypertension.
Rigatto K; Casali KR; Shenoy V; Katovich MJ; Raizada MK
Eur J Pharmacol; 2013 Aug; 713(1-3):89-93. PubMed ID: 23665493
[TBL] [Abstract][Full Text] [Related]
9. Diminazene aceturate uses different pathways to induce relaxation in healthy and atherogenic blood vessels.
Kate Gadanec L; Qaradakhi T; Renee McSweeney K; Matsoukas JM; Apostolopoulos V; Burrell LM; Zulli A
Biochem Pharmacol; 2023 Feb; 208():115397. PubMed ID: 36566945
[TBL] [Abstract][Full Text] [Related]
10. Diminazene protects corpus cavernosum against hypercholesterolemia-induced injury.
Fraga-Silva RA; Costa-Fraga FP; Montecucco F; Sturny M; Faye Y; Mach F; Pelli G; Shenoy V; da Silva RF; Raizada MK; Santos RA; Stergiopulos N
J Sex Med; 2015 Feb; 12(2):289-302. PubMed ID: 25411084
[TBL] [Abstract][Full Text] [Related]
11. Activation of angiotensin-converting enzyme 2 improves cardiac electrical changes in ventricular repolarization in streptozotocin-induced hyperglycaemic rats.
Coutinho DC; Monnerat-Cahli G; Ferreira AJ; Medei E
Europace; 2014 Nov; 16(11):1689-96. PubMed ID: 24741027
[TBL] [Abstract][Full Text] [Related]
12. Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT
Goru SK; Kadakol A; Malek V; Pandey A; Sharma N; Gaikwad AB
Br J Pharmacol; 2017 Sep; 174(18):3118-3130. PubMed ID: 28688122
[TBL] [Abstract][Full Text] [Related]
13. Antiviral potential of diminazene aceturate against SARS-CoV-2 proteases using computational and in vitro approaches.
Santos ES; Silva PC; Sousa PSA; Aquino CC; Pacheco G; Teixeira LFLS; Araujo AR; Sousa FBM; Barros RO; Ramos RM; Rocha JA; Nicolau LAD; Medeiros JVR
Chem Biol Interact; 2022 Nov; 367():110161. PubMed ID: 36116513
[TBL] [Abstract][Full Text] [Related]
14. The small molecule drug diminazene aceturate inhibits liver injury and biliary fibrosis in mice.
Rajapaksha IG; Mak KY; Huang P; Burrell LM; Angus PW; Herath CB
Sci Rep; 2018 Jul; 8(1):10175. PubMed ID: 29977014
[TBL] [Abstract][Full Text] [Related]
15. Anti-hypertensive Effects of Diminazene Aceturate: An Angiotensin- Converting Enzyme 2 Activator in Rats.
De Maria ML; Araújo LD; Fraga-Silva RA; Pereira LA; Ribeiro HJ; Menezes GB; Shenoy V; Raizada MK; Ferreira AJ
Protein Pept Lett; 2016; 23(1):9-16. PubMed ID: 26458404
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effects of diminazene aceturate in pressure-overloaded rat hearts.
Macedo LM; Souza ÁP; De Maria ML; Borges CL; Soares CM; Pedrino GR; Colugnati DB; Santos RA; Mendes EP; Ferreira AJ; Castro CH
Life Sci; 2016 Jun; 155():63-9. PubMed ID: 27153779
[TBL] [Abstract][Full Text] [Related]
17. Diminazene Aceturate, an angiotensin converting enzyme 2 (ACE2) activator, promotes cardioprotection in ischemia/reperfusion-induced cardiac injury.
Coutinho DCO; Santos-Miranda A; Joviano-Santos JV; Foureaux G; Santos A; Rodrigues-Ferreira C; Martins-Júnior PA; Resende RR; Medei E; Vieyra A; Santos RAS; Cruz JS; Ferreira AJ
Peptides; 2022 May; 151():170746. PubMed ID: 35033621
[TBL] [Abstract][Full Text] [Related]
18. Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats.
Foureaux G; Franca JR; Nogueira JC; Fulgêncio Gde O; Ribeiro TG; Castilho RO; Yoshida MI; Fuscaldi LL; Fernandes SO; Cardoso VN; Cronemberger S; Faraco AA; Ferreira AJ
PLoS One; 2015; 10(7):e0133149. PubMed ID: 26204514
[TBL] [Abstract][Full Text] [Related]
19. Is the cardioprotective effect of the ACE2 activator diminazene aceturate more potent than the ACE inhibitor enalapril on acute myocardial infarction in rats?
Badae NM; El Naggar AS; El Sayed SM
Can J Physiol Pharmacol; 2019 Jul; 97(7):638-646. PubMed ID: 30840489
[TBL] [Abstract][Full Text] [Related]
20. Diminazene aceturate (DIZE) has cellular and in vivo antiarrhythmic effects.
Joviano-Santos JV; Santos-Miranda A; Joca HC; Cruz JS; Ferreira AJ
Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):213-219. PubMed ID: 31643111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
